HOME >> MEDICINE >> NEWS
New therapeutic targets for neurodegenerative diseases

The focus of work in the Neurosciences Departments Neurobiology Laboratory at the University of the Basque Countrys Faculty of Medicine and Odontology is the investigation of the molecular and cellular bases of neurodegenerative illnesses those that affect the brain and the spinal cord. Some of these neurodegenerative illnesses are well known and affect a significant part of the population, such as Alzheimers disease and multiple sclerosis.

Researchers at the University of the Basque Country (UPV-EHU) are studying the signals in the central nervous system - the brain and the spinal cord - that do not function well, in particular, those signals that cause the death of nerve cells. There are basically two types of cells in the central nervous system: neurones and the glial cells. Both types are sensitive to these functioning errors and both can die. In the case of Alzheimers disease, it is the neurones, above all, that die. However, in the case of multiple sclerosis, it is a class of glial cells known as oligodendrocytes that perish.

From in vitro cells to biological samples of human origin

The researchers at the Neurobiology Laboratory are investigating cells in cultures - neurones, oligodendrocytes or other cells of the nervous system -, and are trying to reproduce in vitro circumstances that are thought to be relevant in these ailments. That is to say, they are creating the conditions that cause the death of these cells, in order to determine what molecules intervene in the process from the moment of the lethal signal to the point where the cells collapse. In this type of experimental work a series of molecules involved in the death process are identified, the aim being to come up with pharmaceutical medicines that will improve treatment.

Apart from working with in vitro cells, they are also experimenting with animals that reproduce some of the elements involved in neurodegenerative illnesses u
'"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
10-May-2007


Page: 1 2 3

Related medicine news :

1. Shark cartilage shows no benefit as a therapeutic agent for lung cancer
2. OCT1 required for therapeutic effects of diabetes drug Metformin
3. NeuroRx changes name to Neurotherapeutics
4. Olive Leaf report documents promising therapeutic interventions for 9-11 workers
5. T cells activated to fight HIV basis for dendritic cell therapeutic vaccine
6. Cerebrospinal fluid used to deliver therapeutics for Lou Gehrigs disease to brain
7. University to develop new therapeutics for cancer
8. Exubera: So far no evidence available of an additional therapeutic benefit
9. Nano-particles effective in killing cancer with one-two punch of chemotherapeutics
10. Researchers identify target for therapeutic drugs to fight most common adult brain cancer
11. Cedars-Sinai researchers demonstrate a new way to switch therapeutic genes on and off

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New therapeutic targets for neurodegenerative diseases

(Date:10/27/2014)... CA and San Diego, CA (PRWEB) October 27, ... nurse quality indicators database, kicks off its Reliability ... at the U.S. Grant Hotel in downtown San ... experts in a dynamic exchange to advance hospital’s ... , “This year’s conference keynote speakers exemplify the ...
(Date:10/27/2014)... Jiwa Law Corporation now provides Vancouver personal ... motor vehicle accidents. The corporation now assists clients in ... up to a maximum of $150,000. These accident benefits ... medications, home support services, and medical equipment. , ... the way you live your life,” states a company ...
(Date:10/27/2014)... and Atlanta, GA (PRWEB) October 27, 2014 ... cloud-based technologies for the healthcare market, and financial ... offer a fully integrated payment and security solution ... EHR is a cloud-based online, ambulatory Electronic Health ... for small and medium-sized practices. Through the ChARM ...
(Date:10/27/2014)... HealthDay Reporter FRIDAY, Oct. 24, ... hospitals have infection control procedures in place to effectively and ... the 1,039 acute care hospitals that responded to the survey, ... percent said they were "not prepared," according to the Association ... results of the poll paint a disturbing picture, and point ...
(Date:10/27/2014)... Medicines Agency (EMA), an EU agency, has gathered information ... the European ADR database, EudraVigilance. Both authorities and pharmaceutical ... to the database, which provides new knowledge about unknown ... adverse drug reaction reports on asthma medications approved for ... period (2007 to 2011). In the light of the ...
Breaking Medicine News(10 mins):Health News:Healthcare Leaders to Address Reliability and Resiliency in Hospitals 2Health News:Jiwa Law Corporation Now Assists Clients With ICBC Claims for Motor Vehicle Accidents 2Health News:MedicalMine and Bluefin Payment Systems Partner for Integrated Patient Payments in the ChARM EHR Software Platform 2Health News:MedicalMine and Bluefin Payment Systems Partner for Integrated Patient Payments in the ChARM EHR Software Platform 3Health News:Few U.S. Hospitals Ready to Handle Ebola, Survey Finds 2Health News:Few U.S. Hospitals Ready to Handle Ebola, Survey Finds 3Health News:Adverse drug reactions in children following use of asthma medications 2
(Date:10/30/2014)... 29, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, is committed to pursuing ... developed an innovative, patent-pending dual carrier transdermal delivery ... pharmaceutical active ingredients to penetrate the skin and ... The transdermal delivery method also overcomes microbial drug ...
(Date:10/30/2014)... , Oct. 30, 2014 Today Eli ... details of its long-standing technology transfer program to increase ... Begun in 2003, the effort included Lilly donating manufacturing ... in China , India ... South Africa – all MDR-TB ,hot ...
(Date:10/27/2014)... CHICAGO , Oct. 27, 2014  Demonstrations ... and devices are being featured this week in ... 2014 Scientific Assembly where more than 7,000 emergency ... medicine and participating in educational courses. ... back drop of true-to-life emergency department environments, including ...
Breaking Medicine Technology:ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Emergency Medicine of the Future Demonstrated at ACEP14 2Emergency Medicine of the Future Demonstrated at ACEP14 3Emergency Medicine of the Future Demonstrated at ACEP14 4Emergency Medicine of the Future Demonstrated at ACEP14 5Emergency Medicine of the Future Demonstrated at ACEP14 6Emergency Medicine of the Future Demonstrated at ACEP14 7Emergency Medicine of the Future Demonstrated at ACEP14 8Emergency Medicine of the Future Demonstrated at ACEP14 9Emergency Medicine of the Future Demonstrated at ACEP14 10Emergency Medicine of the Future Demonstrated at ACEP14 11Emergency Medicine of the Future Demonstrated at ACEP14 12Emergency Medicine of the Future Demonstrated at ACEP14 13Emergency Medicine of the Future Demonstrated at ACEP14 14Emergency Medicine of the Future Demonstrated at ACEP14 15
Cached News: